Janssen Announces Collaboration with Acino to Strengthen Patient Access in South Africa
"This solid collaboration with Acino will leverage our companies’ commercial capability to ensure enhanced patient access to these products as we commit to leaving no patient behind in South Africa."
Ahmed El Hofy
General Manager, Janssen south africa
JOHANNESBURG, May 15, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson in South Africa (“Janssen”) has entered into a marketing and sales agreement with Acino South Africa (“Acino”), a subsidiary of Acino’s Swiss pharmaceutical company, as part of the company’s commitment to ensure enhanced access and continuity for South African patients to its products.
Under the terms of the agreement, Acino will assume primary responsibility for marketing and selling several products within the Janssen portfolio, mainly in pain, neuroscience, and anti-fungal therapeutic areas.
Speaking on the collaboration, Ahmed El Hofy, General Manager for Janssen South Africa said: “We remain committed to accelerating access in major therapeutic areas to ensure patients in South Africa benefit from our medicines. We strongly believe in the value they bring to the health and wellbeing of current and future patients. This solid collaboration with Acino will leverage our companies’ commercial capability to ensure enhanced patient access to these products as we commit to leaving no patient behind in South Africa.”
The agreement was signed by Ahmed El Hofy, Managing Director, Janssen South Africa and John Norman, Regional Managing Director for Africa at Acino, in a signing ceremony held on 11th May, attended by special guest Deputy Head of Mission from the Belgian Embassy, Mr Bart De Wolf, colleagues from Acino South Africa, and members of the Janssen South Africa Team.
END
CP-389251
# # #
About the Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we're creating a future where disease is a thing of the past. We're the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at https://www.janssen.com/southafrica.